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Introduction
Despite a decrease in the incidence of gastric cancer worldwide, 
gastric cancer has remained as one of the major causes of death in 
Korea.(1) Because of regular endoscopic examinations, however, 
many cases of gastric cancer are diagnosed at an early stage, and 
the prognosis for cases of early gastric cancer after radical gastrec-
tomy is good: the 5-year survival rate is ＞90%, and recurrence 
develops in ＜5%.(2-4) With regard to lymph node metastasis of 
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early gastric cancers, the incidence of such metastasis was reported 
to be 3% in mucosal cancers and approximately 20% in submucosal 
cancers.(5) Due to the development of endoscopic instruments and 
techniques, for patients with a low risk of lymph node metastasis, 
endoscopic resection is performed commonly to improve quality of 
life.(6)
In early gastric cancer, absolute indications for endoscopic re-
section are cases that are well differentiated, confined to the mu-
cosa, and of type I or IIa, measuring ＜2 cm or IIc, measuring ＜1 
cm.(7,8) However, these indications have recently been extended 
to tumors confined to the mucosa without ulceration, regardless 
of size, or with ulceration, measuring ＜3 cm, or those invading 
the superficial submucosal layer (sm1), measuring ＜3 cm.(9,10) 
Accordingly, the trend is that numerous endoscopists aggressively 
perform endoscopic resections.
In endoscopic resection, for incompletely resected cases or for 
cases with the possibility of lymph node metastasis (such as tumors Surgery after Non-curative Endoscopic Resection
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with invasion into the submucosal layer, with lymphovascular inva-
sion, or with poor differentiation by histopathological examination), 
it is generally thought that aggressive surgical treatments are required. 
However, in a recent study, in cases for which the probability of 
lymph node metastasis was low, and only the lateral margin was 
positive, the probability of residual cancer is low, and thus follow 
up observation after re-endoscopic resection is recommended.(11) 
In addition, in numerous studies, a variable number (14~60%) of 
patients without residual cancer after surgery have been reported, 
and thus the absence of residual cancers has been found in many 
patients who had radical gastrectomy.(11,12)
Therefore, in the current study, analysis of the clinicopathologi-
cal characteristics of patients who had surgery after non-curative 
endoscopic resection was done to characterize factors associated 
with residual cancer in these patients; and appropriate treatments 
are discussed.
Materials and Methods 
The study was conducted at the Busan University Hospital 
from January 2006 to June 2009. Subjects were 28 patients who 
had endoscopic resection for early gastric cancer, and for whom 
it was determined that they had non-curative resection. We thus 
performed open or laparoscopic gastrectomy. Indications for en-
doscopic resection at our hospital includes patients who (i) were not 
suspected to have lymph node metastasis and were diagnosed as 
having mucosal cancer by endoscopic ultrasound and abdominal 
computed tomography, (ii) had a well-differentiated and protruded 
type cancer that was smaller than 2 cm, or a well-differentiated 
and depressed type smaller than 1 cm without ulceration or a scar. 
Expanded indications applied only for patients whose surgery risk 
was high or patients who refused surgery.
For endoscopic resection, we used an endoscopic instrument for 
the upper digestive tract with a single channel (GIF-Q260, Olym-
pus, Tokyo, Japan). The margins of the lesions were accurately dis-
tinguished by an endoscopic congo red test. While securing more 
than a minimum 5 mm safety margin in the vicinity of lesions, the 
mucosa was dissected with a needle knife (flex knife, Olympus, 
Tokyo, Japan) turning around 360 degrees, and using an electric 
knife (IT knife, MTW Company, Wesel, Germany). The tissue 
containing the tumor was resected completely from the muscle 
layer along the lower layer of the mucosa.
After endoscopic resection, cases with tumors that had infil-
trated the lateral margin or the vertical margin were determined 
as incomplete resections. Not only incomplete resection also cases 
with a poorly differentiated carcinoma, cases with lymphovascular 
invasion, and cases with tumor infiltration to a depth more than 
500 μm were classified as non-curative endoscopic resections. 
Based on the medical record of these patients, gender, age, en-
doscopic resection methods, surgical methods, tumor size, tumor 
location, and histological classification of tumors were reviewed 
Table 1. Clinicopathological characteristics of the 28 patients who 
underwent surgical resection after endoscopic resection for early 
gastric cancer
Number (%)
Sex
  Male 21 (75)
  Female   7 (25)
  Age (years) 62.6±7.3
Gross
  Elevated   3 (10.7)
  Flat 23 (82.2)
  Depressed 2 (7.1)
Location
  Upper 2 (7.1)
  Middle   5 (17.9)
  Lower 21 (75.0)
Size
  <1 cm   3 (10.7)
  ≥1 cm, <2 cm   8 (28.5)
  ≥2 cm 12 (47.9)
  Unknown   5 (17.9)
Histology
  Well diff  erentiated 11 (39.3)
  Moderately diff  erentiated 12 (42.9)
  Poorly diff  erentiated   4 (14.2)
  Signet ring cell carcinoma 1 (3.6)
Operation method
  LADG with B-I 17 (60.8)
  LADG with B-II 2 (7.1)
  LATG 1 (3.6)
  Subtotal gastrectomy (B-I)   3 (10.7)
  Subtotal gastrectomy (B-II) 2 (7.1)
  Near-total gastrectomy 1 (3.6)
  Total gastrectomy 2 (7.1)
LADG = laparoscopy assisted distal gastrectomy; B-I = billroth I 
anastomosis; B-II = billroth II anastomosis; LATG = laparoscopy 
assisted total gastrectomy.Lee JH, et al.
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retrospectively. These cases were analyzed by dividing them into an 
en bloc resection group and a piecemeal resection group according 
to the method of endoscopic resection. The en bloc resection group 
was divided again into two groups based on a tumor size of ＜3 cm 
or ≥3 cm. Histological classifications were analyzed after dividing 
subjects into (i) a differentiated group including well differentiated 
and moderately well differentiated carcinomas, and (ii) an undif-
ferentiated group including poorly differentiated and signet ring cell 
carcinomas. Patients were also classified according to the cause of 
surgery; they were divided into a group with a high probability of 
lymph node metastasis, a group positive for the lateral margin only, 
a group positive for the vertical margin only and a group positive 
for both lateral and vertical margins.
For statistical analysis, SPSS for Windows (ver. 12.0, SPSS, 
Chicago, IL, USA) was used. For comparisons between the pres-
ence or absence of residual cancers according to clinicopathological 
characteristics, Fisher’s exact test and Linear by linear associations 
were applied. Differences with a P-value less than 0.05 were con-
sidered to be statistically significant.
Results
Of the 28 patients, 21 (75%) were male, and 7 (25%) female. 
The ratio of male to female was 3 : 1. The mean age was 62.6 years 
(range: 48~74) years. Regarding surgical methods, open gastrec-
tomy was done for 8 patients; subtotal gastrectomy with Billroth I 
anastomosis for 3 cases, subtotal gastrectomy with Billroth II for 2, 
near-total gastrectomy with Roux-en-Y gastrojejunostomy for 1, 
and total gastrectomy with Roux-en-Y esophagojejunostomy for 
2. Laparoscopic gastrectomy was done for a total of 20 patients; 
laparoscopy-assisted distal gastrectomy with Billroth I anastomo-
sis for 17, laparoscopy-assisted distal gastrectomy with Billroth 
II anastomosis for 2, and laparoscopy-assisted total gastrectomy 
with Roux-en-Y esophagojejunostomy for 1 case (Table 1). After 
surgery, significant complications did not develop; the average fol-
low up period was 27 months (range: 13~39 months), and cancer 
recurrence or death did not occur.
After surgery, cases showing residual cancer by histopathological 
examination included 8 patients (28.6%), and lymph node metas-
Table 2. Relationship between residual cancer and non-residual cancer according to the pathological characteristics
Residual cancer (N=8) Non-residual cancer (N=20) Total P-value
Resection method (%) 0.015
  En bloc  4 (17.4) 19 (82.6) 23
  Piecemeal  4 (80.0)   1 (20.0) 5
Tumor size (%) 0.067
  ≤3 cm 2 (10.0) 18 (90.0) 20
  >3 cm 2 (66.7)   1 (33.3) 3
Histology (%) 0.123
  Diff  erentiated* 5 (21.7) 18 (78.3) 23
  Undiff  erentiated
† 3 (60.0)   2 (40.0) 5
Lauren classifi  cation (%) 0.017
  Intestinal type 5 (20.0) 20 (80.0) 25
  Diff  use type   3 (100.0) 0 (0) 3
Location of tumor (%) 0.165
  Upper  1 (50.0)   1 (50.0) 2
  Middle 3 (60.0)   2 (40.0) 5
  Lower 4 (19.0) 17 (81.0) 21
Cause of surgery (%) 0.018
  SM2 invasion or lymphovascular invasion 1 (9.1) 10 (90.9) 11
  Positive lateral margin 2 (25.0)   6 (75.0) 8
  Positive vertical margin 1 (33.3)   2 (66.7) 3
  Positive lateral and vertical margin 4 (66.7)   2 (33.3) 6
SM = submucosa. *Well diff  erentiated and moderately diff  erentiated; 
†Poorly diff  erentiated and signet ring cell type.Surgery after Non-curative Endoscopic Resection
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tasis was detected in 1 patient (3.6%). According to the endoscopic 
resection methods, among 23 patients who had en block resection, 
residual cancer was detected in 4 patients (17.4%). On the other 
hand, in the group who had piecemeal resection, residual cancer 
was found in 4 of 5 patients (80.0%), and thus residual cancer was 
significantly higher in the piecemeal resection group (P=0.015). In 
cases where the tumor was resected en bloc, the incidence of re-
sidual cancer depended on the size of the endoscopically resected 
cancer: 2 of 20 patients (10.0%) had residual cancer in cases where 
the tumor was smaller than 3 cm; for tumors larger than 3 cm, 2 of 
3 patients (66.7%) showed residual cancer; However, this difference 
was not statistically significant. According to Lauren’s classification, 
in the intestinal type of gastric cancer, 5 of 25 patients (20.0%) had 
residual cancer; in the diffuse type, 3 of 3 (100.0%) showed residual 
cancer; and the difference was statistically significant (P=0.017). 
In the group in which the lateral margin and the vertical margin 
were negative, but the cancer had invaded the submucosal layer or 
lymphovascular duct, 1 of 11 patients (9.1%) had residual cancer. In 
the group positive for the lateral margin only, 2 of 8 patients (25.0%) 
had residual cancer. In the group positive for the vertical margin 
only, 1 of 3 patients (33.3%) showed residual cancer. In the group 
positive for both the lateral margin and the vertical margin, residual 
cancer was detected in 4 of 6 patients (66.7%), and the difference 
was statistically significant (P=0.018) (Table 2).
Discussion
The worldwide incidence of early gastric cancer is variable. In 
Japan, it accounts for 50% of all cases of gastric cancer. In Korea, 
according to the Korean Gastric Cancer Society, early gastric can-
cer accounts for approximately 33% of cases of gastric cancer, and 
the trend is towards a gradual increase in the proportion.(13,14) 
Therefore, recently, treatment methods have changed greatly. The 
standard treatment for gastric cancer was radical gastrectomy. For 
early gastric cancer with a low risk of lymph node metastasis, en-
doscopic resection has been done in many cases to achieve a better 
quality of life. Nevertheless, in cases of early gastric cancer that 
have invaded into the submucosal layer, lymph node metastasis has 
been reported to be present in up to 20%. Thus, it is accepted that 
after endoscopic resection, for the group for which the possibility of 
lymph node metastasis is relatively high, radical gastrectomy should 
be performed.(8,15-17) In our study, similarly, in 27 patients with 
invasion to SM2, where the possibility of lymph node metastasis is 
high, 1 of 27 patients (3.7%) showed lymph node metastasis, and 
we found that this cannot be ignored.
Korenaga et al.(18) reported that among 11 patients who had 
gastrectomy after incomplete endoscopic mucosal resection, re-
sidual cancer was detected in 4 of 5 patients with invasion of tu-
mors into the margin of the resection area; residual cancer was 
detected in 3 of 6 patients with invasion into the submucosal layer. 
Nagano et al.(11) reported that in cases of submucosal cancer, or 
with a positive vertical margin after endoscopic mucosal resection, 
the possibility of the presence of residual cancer is high, and thus 
radical gastrectomy is required. In cases limited to the mucosa and 
invasion into the lateral margin, residual cancer was detected in 5.8% 
(18/309). On the other hand, in cases with invasion into the sub-
mucosal layer and invasion of tumors into the vertical margin, the 
ratio of residual cancer was high - it was 15.4% (6/39). In a recent 
study, in lesions that invaded the lateral margin, the possibility of 
the presence of residual cancer was low, and it has been proposed 
that re-endoscopic resection should be done.(19) Actually, in re-
endoscopic resection, there are problems due to the scar of the 
previous resection, it is difficult to separate the submucosal layer, 
and the location of residual cancer is difficult to assess accurately. 
Hence, if the entire scar area is resected, the possibility of conse-
quent complications such as hemorrhage is high. In our study, even 
in the group with negative resection margins, residual cancer was 
detected in 1 patient, and thus it is thought that even if the resection 
margin after en bloc resection is negative, a comprehensive follow-
up observation is required. In addition, the rate of residual cancer in 
the group whose lateral margin was positive was significantly lower 
than in the group whose vertical margin was positive, and the dif-
ference was statistically significant. Nonetheless, in cases whose 
lateral margin was positive, residual cancer was detected in 25% of 
patients, which is not a small proportion, and thus it is difficult to 
determine treatment protocols based on these results alone.
The principle of endoscopic resection is to use en bloc resec-
tion because of the possibility of residual cancer cells remaining 
if piecemeal resection is performed. Oda et al.(20) reported that 
among 714 patients who had endoscopic resection, endoscopic 
mucosal resection was done on 411 patients, and endoscopic sub-
mucosal dissection was done on 303 patients. The en bloc resec-
tion rate of endoscopic submucosal dissections (97.2%) was higher 
than that of endoscopic mucosal resections (56.0%), and the ratio 
of curative resection was significantly higher in the group who had 
endoscopic submucosal dissection (73.6%). The 3-year disease-
free survival rate was also higher in the group who had endoscopic 
submucosal dissection. In our study, similarly, in comparison with Lee JH, et al.
186
the endoscopic en bloc resection group (17.4%), the ratio of residual 
cancer in the piecemeal resection group was higher, and thus it is 
thought that for the piecemeal resection group, aggressive treat-
ments are required.
In our study, in cases with undifferentiated cancers as deter-
mined by histological classification, residual cancer was detected 
in 60% of cases, and thus it was higher than the proportion in the 
differentiated cancer group; but the difference was not statistically 
significant. However, using Lauren’s classification, residual cancer 
was present in all diffuse types, which suggests that after endo-
scopic resection, if the tumor is of the diffuse type, comprehensive 
observation and treatments are required.
In regard to the site of tumors, it is thought that in the upper and 
middle third of the stomach, where endoscopic resection is rela-
tively difficult technically, residual cancer would be abundant, and 
residual cancers were detected in 50% in the upper third, in 60% 
in the middle third, and in 19% in the lower third. In comparison 
with the upper and middle third, the ratio of residual cancer in the 
lower third was low, but, since the number of cases was small, the 
difference was not statistically significant.
After endoscopic resection, in cases of non-curative resection, 
surgical treatments for the patients could not only completely resect 
lesions, but also, a complete pathological evaluation could be per-
formed through lymphadenectomy. On the other hand, recurrent 
lesions are mucosal lesions in most cases. Hence, some experts have 
expressed the concern that it may lead to excessive treatments.(19) 
Therefore, it is thought if factors associated with a low possibility 
of residual cancer could be found, minimal invasive procedures for 
such patients, such as follow-up observation after re-endoscopic 
resection may be adequate and radical gastrectomy not warranted. 
In our study, in the en bloc resection group, the intestinal type 
group, and the group in which only the lateral resection margin was 
positive, the ratio of residual cancer was significantly lower, and 
thus it is thought that radical gastrectomy for such patients should 
be reconsidered. However, in the piecemeal resection group, the 
diffuse type group, or the group with lateral as well as vertical mar-
gins being positive, residual cancer is abundant and surgery must be 
done.
In our study, although the number of subjects was small, we 
conclude that patients who underwent piecemeal endoscopic re-
sections, patients who have diffuse type tumors, or patients whose 
lateral margin and vertical margin are positive, should be treated 
by surgery because the incidence of residual cancer is significantly 
high. On the other hand, a minimally invasive procedure such as 
re-endoscopic resection and careful follow-up can be considered 
for patients who have a positive lateral margin and the intestinal 
type of cancer (after en block endoscopic resection) because the 
possibility of the presence of residual cancer is low. However, to 
establish appropriate treatment principles, more studies are required 
in the future. 
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